Podlesak Dennis
SEC insider (Form 3/4/5 filer). CIK 0001314595. Director at Syndax Pharmaceuticals Inc (SNDX). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 4, 2026. Located in NEW YORK, NY.
Companies Podlesak Dennis has filed insider reports for
- Syndax Pharmaceuticals Inc (SNDX): Director
Podlesak Dennis
CIK: 0001314595
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syndax Pharmaceuticals Inc
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 4, 2026SNDX
Syndax Pharmaceuticals Inc
AwardDirect48K shares- - Aug 18, 2025SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect19.2K shares at avg. $7.20$138K - Aug 18, 2025SNDX
Syndax Pharmaceuticals Inc
SaleDirect19.2K shares at avg. $15.84$304K - Aug 15, 2025SNDX
Syndax Pharmaceuticals Inc
SaleDirect19.2K shares at avg. $15.54$298K - Aug 15, 2025SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect19.2K shares at avg. $7.20$138K - Aug 14, 2025SNDX
Syndax Pharmaceuticals Inc
SaleDirect19.2K shares at avg. $14.19$273K - Aug 14, 2025SNDX
Syndax Pharmaceuticals Inc
ExerciseDirect19.2K shares at avg. $7.20$138K - Feb 5, 2025SNDX
Syndax Pharmaceuticals Inc
AwardDirect50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 4, 2026 | SNDX Syndax Pharmaceuticals Inc | Award | 48,000 | - | $0 | Direct |
| Aug 18, 2025 | SNDX Syndax Pharmaceuticals Inc | Exercise | 19,200 | $7.20 | $138,240 | Direct |
| Aug 18, 2025 | SNDX Syndax Pharmaceuticals Inc | Sale | 19,200 | $15.84 | $304,170 | Direct |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | Sale | 19,200 | $15.54 | $298,408 | Direct |
| Aug 15, 2025 | SNDX Syndax Pharmaceuticals Inc | Exercise | 19,200 | $7.20 | $138,240 | Direct |
| Aug 14, 2025 | SNDX Syndax Pharmaceuticals Inc | Sale | 19,200 | $14.19 | $272,521 | Direct |
| Aug 14, 2025 | SNDX Syndax Pharmaceuticals Inc | Exercise | 19,200 | $7.20 | $138,240 | Direct |
| Feb 5, 2025 | SNDX Syndax Pharmaceuticals Inc | Award | 50,000 | - | - | Direct |
1-8 of 8 transactions